International Pharma Congress: Home

	THE SECOND INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Transformational Learning - Effective Knowledge Exchange
May 28 - 29, 2008 Paris Marriott Rive Gauche Hotel and Conference Center Paris, France

2008 INTERNATIONAL PHARMA CONGRESS MULTIMEDIA

Watch video of the 2008 International Pharma Congress on the go. The International Pharma Congress offers Podcasting of all general sessions on a 30gb Video iPOD™, a DVD-ROM, or a Flash Drive. Concurrent breakout session audio and all related presentation materials are also included on each multimedia format.

Click here to order!

PRECEDED IMMEDIATELY BY THE INTERNATIONAL DEVICE CONGRESS

THE INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by AdvaMed, Eucomed, ABHI, APPAMED, BVMed, COCIR, EDMA, MEDEC, MIAA, SNITEM, Harvard Health Policy Review and Health Affairs
May 26 - 27, 2008
Paris Marriott Rive Gauche Hotel, Paris, France
www.InternationalDeviceCongress.com

CONGRESS CHAIRS

Steve Mohr, Esq.
Global Compliance Officer, AstraZeneca, London, UK

Lori Queisser
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Kenilworth, NJ, USA

Roeland van Aelst
Executive Director, Health Care Compliance, Europe, Middle East Africa, Johnson & Johnson, Brussels, Belgium

KEYNOTE SPEAKERS

Richard Bergstrom, MScPharm Managing Director, Swedish Association of the Pharmaceutical Industry, Stockholm, Sweden
Nicola Bonucci Director of Legal Affairs, Organization for Economic Co-Operation and Development, Paris, France
Fergal Donnelly Directorate-General for Research, European Commission, Brussels, Belgium
Justin MacMullan Head of Campaigns, Consumer International, London, UK

Jaak Peeters Chairman, Europe, the Middle East and Africa, Janssen-Cilag, Neuss, Germany
Dr. Gunther Puhn Senior Public Prosecutor, Court of Appeal, Munich, Germany
Jean-Bernard Schmid Investigating Magistrate, Republic and Canton of Geneva, Geneva, Switzerland
Louis Schweitzer Chairman, AstraZeneca PLC, Chairman and Former Chief Executive Officer, Renault, Vice-Chairman, Philips, Board Member, AB Volvo, BNP Paribas,Veolia Environnement, Chairman of the Supervisory Board, Le Monde, Commander, French Legion of Honor, Paris, France

FEATURED PHARMA COMPLIANCE PROFESSIONALS

Gonzalo M. Cornejo, Esq.
Vice President and Associate General Counsel, Legal Operations International and Japan, GlaxoSmithKline, Philadelphia, PA

Gabor Danielfly
Senior Director, Global Compliance & Business Practices, Schering-Plough Corporation, Levallois-Perret Cedex, France

Julien Durand
Director, Global Compliance Implementation, AstraZeneca PLC, London, UK

Sue Egan
Compliance Officer, International Sales & Marketing, AstraZeneca, London, UK

Michael Fadus
Compliance Officer, Schering-Plough Central East AG, Switzerland

Christine S. Fields, Esq.
General Counsel, International Operations, Eli Lilly and Company, Indianapolis, IN, USA

Anna Frick
Director Conference & Exhibition Management, AstraZeneca PLC, Delegate, International Pharmaceutical Advisory, Association, London, UK

Gerard Geneen
Compliance Officer, Pharmaceuticals Europe, GlaxoSmithKline, Brentford, Middlesex, UK

Gary F. Giampetruzzi, Esq.
Deputy Compliance Officer, International Investigations and Programs, Pfizer Inc., New York, NY, USA

Andrew Hayward, Esq.
Chief Counsel, Global Compliance, AstraZeneca PLC, London, UK

Joe Henein
Managing Director, Middle East and North Africa, Wyeth Pharmaceuticals, Chairman, LAWG ethics committee, Dubai, United Arab Emirates

Jose F. Zamarriego Izquierdo
Director, Code of Practice Surveillance Unit, Farmaindustria, Madrid, Spain

Ann Leopold Kaplan, Esq.
Assistant General Counsel, PhRMA, Washington, DC, USA

Georgia Keresty
Senior Vice President Pharmaceutical Compliance, and Global Regulatory Affairs, Johnson & Johnson, New Brunswick, NJ, USA

John Knight, MD, FRACP
Senior Medical Advisor, Benefit Risk Management, Johnson & Johnson, Sydney, Australia

Juan Francisco Millan, MD
Executive Director, CETIFARMA (Pharma Industry Association), Mexico

Arthur Muratyan, Esq.
Vice President Legal Corporate, Sanofi Aventis, Paris, France

Dave O'Shaughnessy
Compliance Officer, Pharmaceuticals International, GlaxoSmithKline, London, UK

Christian Skak Olufsen
Vice President, Novo Nordisk, Bagsvaerd, Denmark

Dan Ostergaard
Head of Corporate Integrity & Compliance, Novartis International AG, Basel, Switzerland

Bina Patel
Global Clinical Safety & Pharmacovigilance, GlaxoSmithKline, London, UK

Michael Shaw, Esq.
Global Head, Ethics and Compliance, Novartis Oncology, Former Senior Counsel, Office of Inspector General, Department of Health & Human Services, Florham Park, NJ, USA

Valerie E. Simmons, MD
Qualified Person, Pharmacovigilance, Global Patient Safety, Eli Lilly & Company Ltd. London, UK

Carlos G. Tessi, MD
Vice President, Global Human Health Business Practices and Compliance, Merck

Yuet-Ming Tham, Esq.
Regional Compliance Director, Legal Division, Corporate Compliance, Pfizer Inc., Hong Kong

Adrian Thomas, MD, FRACP
Chief Safety Officer and Global Head Benefit Risk Management, Johnson & Johnson, Horsham, PA, USA and High Wycombe, UK

Margaret Walters
Deputy Qualified Person, Merck Sharpe & Dohme, London, UK

Sigrid Willame
Vice President, Legal Affairs, UCB Group, Brussels, Belgium

Crawford Wright
Chief Compliance and Privacy Officer, AstraZeneca PLC, Ontario, Canada

Jose Zamarriego
Chairman, Pharmaindustria, Madrid, Spain

FEATURED LEADING ACADEMICS

Kathleen M. Boozang, Esq.
Associate Dean and Professor of Law, Seton Hall University School of Law, Newark, NJ, USA

Carl Coleman
Professor of Law and Director, Health Law and Policy Program, Seton Hall Law School, Newark, NJ, USA

Adeyinka G. Falusi, PhD
Professor of Hematology, Head, Genetic & Bioethics Research Unit, Institute for Advanced Medical Research & Training, College of Medicine, University of Ibadan, Ibadan, Nigeria

John Williams, PhD
Director of Ethics, World Medical Association, Coordinator, Revision of the Declaration of Helsinki, Adjunct Professor, Department of Medicine, University of Ottawa and Dept. of Philosophy, Carleton University, Ottawa, Canada

FEATURED LEADING PHARMA CONSULTANTS AND LEGAL COUNSEL

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Assistant Inspector General for Legal Affairs, Office of Inspector General, US Department of Health and Human Services, Paris, France

John Bentivoglio, Esq.
Partner, King & Spalding LLP, Former Special Counsel for Health Care Fraud and Chief Privacy Officer, United States Department of Justice Washington, DC, USA

Christine Bendall
Consultant, Arnold & Porter LLP, London, UK

Ian Dodds-Smith, Esq.
Partner and Co-Head, Food, Drug and Medical Devices Practice Group and Head, European Product Liability Practice Group, Arnold & Porter LLP, London, UK

Paul V. Gerlach, Esq.
Partner and Chair SEC Enforcement Practice, Sidley Austin LLP, Former Associate Director, Division of Enforcement, US Securities & Exchange Commission, Washington, DC, USA

Wendy C. Goldstein, Esq.
Member of the Firm, Epstein Becker & Green, New York, NY, USA

Debjit Ghosh
Director, National Life Sciences Practice, Huron Consulting Group, New York, NY

Linda Horton, Esq.
Partner, Hogan & Hartson LLP, Washington, DC, USA and Brussels, Belgium

Jonathon L. Kellerman
Partner, Advisory Health Industries, Pharmaceutical and Medical Device Sector, PricewaterhouseCoopers LLP, Philadelphia, PA, USA

Keith M. Korenchuk, JD, MPH
Of Counsel, Covington & Burling LLP, Washington, DC, USA

Daniel A. Kracov, Esq.
Partner and Global Head, Pharmaceutical and Medical Devices Practice, Arnold & Porter, Washington, DC

Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission Legal Service, Brussels, Belgium

Monika Pietrek, MD, PhD, MSc
Drug Development and Safety Expert, Weinheim, Germany

Ethan M. Posner, Esq.
Partner, Covington & Burling LLP, Former Deputy Associate Attorney General, US Department of Justice, Washington, DC, USA

Carla Schoonderbeek Nauta Dutilh, Esq.
Partner, NautaDutilh, Amsterdam, Holland

Paul J. Silver
Managing Director, National Life Sciences Practice, Huron Consulting Group, Atlanta, GA

John Smart
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, London, UK

Thomas H. Suddath, Jr.
Partner, Reed Smith; Former Assistant United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA, USA

Dr. Lincoln Tsang
Partner, Arnold & Porter LLP, London, UK

Emmanuelle M. Voisin, PhD
Principal, Voisin Consulting, Former General Manager of Quintiles France and Spain, Paris, France

Elisabethann Wright, Esq.
Counsel, Hogan & Hartson LLP, Brussels, Belgium

FEATURING THE FOLLOWING PRECONFERENCE SESSIONS

Preconference II: Global Compliance Program Operational Issues: Infrastructure, Monitoring, Auditing and Managing with Limited Resources
Preconference II: Comparing, Contrasting and Complying with the Various Global Codes of Conduct
Preconference III: Advanced Issues in Promotion, Inducements and Corrupt Practices, including Foreign Corrupt Practices Act
Preconference IV: An Overview of the United State Regulatory Environment (FDA and Healthcare) for Global Pharmaceutical Compliance Professionals

THE FOLLOWING TRACKS

Track I: Promotion, Inducements and Corrupt Practices, including Foreign Corrupt Practices Act
Track II: Pharmacovigilance and Drug Safety
Track III: International Clinical Trials
Track IV: Practical Case Studies: Third Party Oversight, Distribution Channel Challenges and Global Fair Market Value

THESE SPECIAL SESSIONS

Setting the Stage: Crucial Issues in International Compliance Panel
Emerging Compliance Issues in Europe, Middle East, Africa, Asia and Latin America
Global Compliance Perspective's from a Former Compliance Officer
EFPIA and IFPMA Code Compliance Strategies
Inside the Bribery Probe of Siemens
International Congresses, Including Booth Materials and Panels, Non-CME Medical Presentations Controls, and Interactions Between Commercial Associates and HCPs before/after CME Events: Which Guidelines Apply?

AND A COMPANY BEST COMPLIANCE PRACTICE POSTER BOARD RECEPTION

The International Device Congress Networking Reception on Wednesday, May 28, 2008 will feature the exchange and presentation of company best practice policy and procedures at poster boards throughout the International Pharma Congress Exhibit Hall.

INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE

Ted Acosta, Esq.
Principal, Ernst & Young LLP

John T. Bentivoglio, Esq.
Partner, King & Spalding LLP

Kathleen Boozang, Esq.
Associate Dean for Academic Affairs, Cofounder, Health Law & Policy Program, and Health Law, Science and Technology Graduate Programs, Seton Hall Law School

Sujata Dayal
Ethics and Compliance Officer, Pharmaceutical Products Division, Abbott Laboratories

Ian Dodds-Smith, Esq.
Partner, Arnold & Porter

Sue Egan
Vice President Compliance, AstraZeneca

Gerard Geneen
Compliance Officer, Pharma Europe, GlaxoSmithKline

Wendy C. Goldstein, Esq.
Partner, Epstein Becker & Green

Linda Horton, Esq.
Partner, Hogan & Hartson LLP

Paul Kalb, Esq.
Partner, Sidley Austin LLP

Georgia Keresty
Senior Vice President Pharmaceutical Compliance and Global Regulatory Affairs, Johnson & Johnson

Keith M. Korenchuk, JD, MPH
Of Counsel, Covington & Burling LLP

Dominique Laymand
Senior Director Compliance, Bristol-Myers Squibb

Maxine Nogard
International Compliance Officer, Wyeth

Dave O'Shaunessy
Compliance Officer, Pharmaceuticals International, GlaxoSmithKline

Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP

Christian Skak Olufsen
Vice President, Novo Nordisk

Michael Shaw
Global Head, Ethics & Compliance, Novartis Oncology

Paul J. Silver
Managing Director, National Life Sciences Practice, Huron Consulting Group

Michael Stephens
Senior Director, Global Ethics and Compliance, Merck

SAVE THE DATE

NINTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
October 27 - 29, 2008
Hyatt Regency On Capitol Hill
Washington, DC
www.PharmaCongress.com

BUY CD-ROM ON THE FIRST INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS

Sponsored by Pharmaceutical Compliance Forum
June 6 - 7, 2007
Brussels, Belgium
www.InternationalPharmaCongress.com

CD-ROM includes audio of all International Pharma Congress general sessions (preconfernce sessions not included) and all speaker presentations.

Click here to order.

SPONSORED BY:

GRANTORS:

DIAMOND

BRONZE

PUBLICATION SPONSORS

SAVE THE DATES

THIRD ANNUAL MEDICAL DEVICE REGULATORY, REIMBURSEMENT AND COMPLIANCE CONGRESS AT HARVARD
Sponsored by AdvaMed, Harvard Health Policy Review and Health Affairs
March 26 - 28, 2008
Harvard University
Cambridge, MA
www.DeviceCongress.com